Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2006-12-02
2009-10-13
Mosher, Mary E (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C424S204100, C424S209100, C435S006120, C435S029000, C435S235100, C514S888000
Reexamination Certificate
active
07601490
ABSTRACT:
The present invention includes compositions, methods and systems to isolate and characterize novel antiviral agents by contacting the antiviral agent with the F2F3 zinc fingers of a CPSF30 protein and an Influenza A NS1A protein; and determining whether the binding between the CPSF30 protein and the Influenza A NS1A protein is reduced.
REFERENCES:
patent: 2005/0191703 (2005-09-01), Palese et al.
patent: 2005/0233963 (2005-10-01), Moseley et al.
Salvatore and Garcia-Sastre. Virus versus host: modulation of the host a/b interferon pathways by the inf luenza A virus NS1 protein. International Congress Series 1219 (2001) 513-520.
Yoneyama, et al. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. The EMBO Journal. 1998, vol. 17 No. 4 pp. 1087-1095.
Ohnishi, et al. Mechanism of Host Defense Suppression Induced by Viral Infection: Mode of Action of Inosiplex as an Antiviral Agent. Infection and Immunity, Oct. 1982, vol. 38, No. 1: p. 243-250.
Barabino, S. M., et al., “The 30-kD subunit of mammalian cleavage and polyadenylation specificity factor and its yeast homolog are RNA-binding zinc finger proteins.” Genes Dev (1997), 11:1703-16.
CDC (Center for Disease Control). 2005. Key facts about influenza and the influenza vaccine. http://www.cdc.gov/flu/keyfacts.htm.
Chen, Z., Y. Li, et al., “Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery.” EMBO J (1999), 18:2273-83.
Cox, N. J., et al., “Influenza.” Lancet (1999), 354:1277-82.
Ferguson, N. M., et al., “Strategies for containing an emerging influenza pandemic in Southeast Asia.” Nature (2005), 437:209-14.
Geiss, G. K., et al., “Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza.” Proc Natl Acad Sci U S A (2002), 99:10736-41.
Kim, M. J., et al., “Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique.” Proc Natl Acad Sci U S A (2002), 99:10096-101.
Kiso, M., K. et al., “Resistant influenza A viruses in children treated with oseltamivir: descriptive study.” Lancet (2004), 364:759-65.
Le, Q. M., et al., “Avian flu: isolation of drug-resistant H5N1 virus.” Nature (2005), 437:1108.
Li, Y., et al., “The 3′-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo.” RNA (2001), 7:920-31.
Longini, I. M., Jr., et al., “Containing pandemic influenza at the source.” Science (2005), 309:1083-7.
Longtine, M. S., et al., “Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae.” Yeast (1998), 14:953-61.
Nemeroff, M. E., et al., “The influenza virus NS1 protein forms multimers in vitro and in vivo.” Virology (1995), 212:422-8.
Nemeroff, M. E., et al., “Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3′end formation of cellular pre-mRNAs.” Mol Cell (1998), 1:991-1000.
Noah, D. L., et al., “Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS.” Virology (2003), 307:386-95.
Puthavathan, P., et al., “Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand.” J Gen Virol (2005), 86:423-33.
Qiu, Y., et al., “The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A).” J Virol (1994), 68:2425-32.
Reid, A. H., et al., “The 1918 Spanish influenza: integrating history and biology.” Microbes Infect (2001), 3:81-87.
Shimizu, K., A. Iguchi, R. Gomyou, and Y. Ono. 1999. Influenza virus inhibits cleavage of the HSP70 pre-mRNAs at the polyadenylation site. Virology (1999), 254:213-9.
Suzuki, H., et al., “Emergence of amantadine-resistant influenza A viruses: epidemiological study.” J Infect Chemother (2003), 9:195-200.
Yuan, W., et al., “Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein.” EMBO J (2001), 20:362-71.
International Search Report and Written Opinion for PCT/US2006/046234 dated Dec. 21, 2007.
Krug Robert M.
Twu Karen Y.
Board of Regents , The University of Texas System
Chalker Flores LLP
Flores Edwin S.
Mosher Mary E
Singleton Chainey P.
LandOfFree
Development of influenza A antivirals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Development of influenza A antivirals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Development of influenza A antivirals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4065302